hSNCA(2)

Nomenclature

C57BL/6JSmo-Sncatm1(hSNCA)Smoc

Cat. NO.

NM-HU-251485

Strain State

Repository Live

Export PDF

Gene Summary

Gene Symbol
Snca

Model Description

The endogenous mouse Snca gene was replaced by human SNCA gene.

Validation Data

image.png

Fig.1 Detection of SNCA expression in WT mice and hSNCA(2) mice by WB. α-synuclein (SNCA) was detectable at a similar level in hippocampus and cortex from both WT C57BL/6 and HE hSNCA(2) mice with an antibody which is cross-reactived between human and mouse SNCA. The hippocampus and cortex lysates were collected from 12-week-old female WT C57BL/6 mice and 7-week-old male heterozygous hSNCA(2) mice, and then analyzed by western blot with an anti-human/mouse SNCA antibody. 

Abbr. HE, heterozygous; WT, wild type. M, marker.

image.png

Fig.2 Detection of human SNCA expression in WT mice and hSNCA(2) mice by WB. Human α-synuclein (SNCA) was exclusively detectable in hippocampus and cortex from HE hSNCA(2) mice with a human SNCA-specific antibody. The hippocampus and cortex tissue lysates were collected from 12-week-old female WT C57BL/6 mice and 7-week-old male heterozygous hSNCA(2) mice, and then analyzed by western blot with an anti-human SNCA antibody. 

Abbr. HE, heterozygous; WT, wild type; M, marker.

image.png

Fig.3 Detection of SNCA expression in heart, pancreas, small intestine and frontal lobe by RT-PCR. Mouse Snca mRNA (168 bp) was detectable only in wild-type C57BL/6 mice. Human SNCA mRNA (120 bp) was detectable only in homozygous hSNCA(2) knockin mice but not in wild-type mice. Heart, pancreas, small intestine and frontal lobe RNA was extracted from 7-week-old female wild-type C57BL/6 mice (n=2) and homozygous hSNCA(2) knockin mice (n=2), then cDNA libraries were synthesized by reverse transcription, followed by PCR with mRNA primers. 

Abbr. M, marker; HO, homozygous; WT, wild type.



You may also like

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

Learn more

Workshop:Progress and Advances in Preclinical immuno-Oncology Research

SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.

Learn more

Customizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!

At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.

Learn more